| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/07/2004 | EP1377610A2 Osteoprotegerin in milk |
| 01/07/2004 | EP1377609A2 Mhc molecule constructs and their uses for diagnosis and therapy |
| 01/07/2004 | EP1377593A2 2-amino-propanol derivatives |
| 01/07/2004 | EP1377589A1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 01/07/2004 | EP1377579A2 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| 01/07/2004 | EP1377576A2 Pyridine derivatives |
| 01/07/2004 | EP1377574A1 6-phenylbenzonaphthyridines |
| 01/07/2004 | EP1377572A1 Isoxaxole derivatives as inhibitors of src and other protein kinases |
| 01/07/2004 | EP1377567A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 01/07/2004 | EP1377560A1 Piperazine derivatives as tachykinin antagonists |
| 01/07/2004 | EP1377559A2 Rxr activating molecules |
| 01/07/2004 | EP1377558A1 [1,4]-diazepane-1-carboxylic acid derivatives, process for their preparation and their use as tachykinin antagonists |
| 01/07/2004 | EP1377556A1 Pyrazole derivatives for treating hiv |
| 01/07/2004 | EP1377555A1 Novel compounds |
| 01/07/2004 | EP1377554A1 Antagonism of immunostimulatory cpg-oligonucleotides by 4-aminoquinolines and other weak bases |
| 01/07/2004 | EP1377553A1 Tetrahydroquinoline derivatives as stat6-modulators, preparation and use thereof |
| 01/07/2004 | EP1377301A2 Normalization of defective t cell responsiveness through manipulation of thymic regeneration |
| 01/07/2004 | EP1377299A2 Transcutaneous immunostimulation |
| 01/07/2004 | EP1377291A2 1-butyric acid derivatives such as carbomethoxypropionyl cyanide or leflunomide derivatives, and the therapeutic use thereof |
| 01/07/2004 | EP1377288A1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and method |
| 01/07/2004 | EP1377282A2 Aryl-n-cyanoguanidines and methods related thereto |
| 01/07/2004 | EP1377276A2 Timed pulse release composition |
| 01/07/2004 | EP1377275A2 Vaccine for modulating between t1 and t2 immune responses |
| 01/07/2004 | EP1289997B1 Macrolides |
| 01/07/2004 | EP1175417B1 Substituted benzolactam compounds |
| 01/07/2004 | EP1082119B1 Microemulsion preconcentrates containing a piperidine substance p antagonist |
| 01/07/2004 | EP0661992B1 Pharmaceutical formulations of interleukin-1 inhibitors |
| 01/07/2004 | EP0600880B1 Interleukin 1- beta protease and interleukin 1-beta protease inhibitors |
| 01/07/2004 | CN1466591A Nucleoside derivatives |
| 01/07/2004 | CN1466586A Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 01/07/2004 | CN1466577A 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 01/07/2004 | CN1466576A Quinolne-(C=O)-CD1, tri-and tetrapeptide) derivatives as caspase inhibitors |
| 01/07/2004 | CN1466573A 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis |
| 01/07/2004 | CN1466569A Novel 3-substituted urea derivatives and medicinal use thereof |
| 01/07/2004 | CN1466463A Remedies for ischemic diseases |
| 01/07/2004 | CN1466456A Sgk2 and Sgk3 used as diagnostic and therapeutic targets |
| 01/07/2004 | CN1466454A Method of treating symptons of common cold allergic rhinitis and infections relating to the respiratory tract |
| 01/07/2004 | CN1466453A Fatty acid analogues for the treatment of proliferative skin disorders |
| 01/07/2004 | CN1466451A Ion-strength independent sustained release pharmacetuical formulation |
| 01/07/2004 | CN1465696A Polypeptide-trorsine 14 and polynucleotide for coding said polypeptide |
| 01/07/2004 | CN1465597A Fusion protein containing soluble tumor necrosis factor II type receptor and interleukin I receptor agonist IL1Ra its preparation process and medicine composition |
| 01/07/2004 | CN1465355A Acellular short corynebacteria preparation |
| 01/07/2004 | CN1465353A Becterin of Serratia marcescens for curing |
| 01/07/2004 | CN1133647C Heterocyclic compound used as leucocyte adherence inhibitor and VLA-4 antagonist |
| 01/07/2004 | CN1133643C Lactone derivatives of 17-beta-carboxy, carbothio and amide androstane derivatives |
| 01/07/2004 | CN1133637C Triptolide analogs and composition and use thereof |
| 01/07/2004 | CN1133466C Gelling ophthalmic composition containing xanthan gum |
| 01/07/2004 | CN1133464C Pharmaceutical compositions for controlled release of soluble receptors |
| 01/07/2004 | CN1133460C Pharmaceutical compositions of macrolides or cyclosporine with polyethoxylated saturated hydroyfatty acid |
| 01/07/2004 | CN1133434C Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 01/07/2004 | CN1133424C Repamycin formulations for oral administration |
| 01/06/2004 | US6675105 Structure-based identification of candidate compounds using three dimensional structures and models of Fc receptors |
| 01/06/2004 | US6673965 Hydroxamic acid derivative as inhibitor of the formation of soluble human CD23 |
| 01/06/2004 | US6673897 Inhibitors of NF-κB Activation |
| 01/06/2004 | US6673825 Urazole compounds useful as anti-inflammatory agents |
| 01/06/2004 | US6673807 Administering compound possessing inhibitory activity on production of nitric oxide and tricyclic macrolide or salt, solvate or hydrate thereof to increase graft survival time in transplantation subject |
| 01/06/2004 | US6673803 Quinazoline derivatives and pharmaceutical compositions containing them |
| 01/06/2004 | US6673798 PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 01/06/2004 | US6673794 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 01/06/2004 | US6673782 Treating proteinuria and swollen lymph node symptoms by administering an effective dose of a vitamin d analog to a patient on a diet which includes a calcium intake level of >800mg/day per 160 pound patient |
| 01/06/2004 | US6673777 Guanylhydrazones useful for treating diseases associated with T cell activation |
| 01/06/2004 | US6673770 Peptides for the treatment, prophylaxis, diagnosis and monitoring of autoimmune diseases |
| 01/06/2004 | US6673573 Expression of immunoglobulin-cytokine fusion proteins in malignant B cells |
| 01/06/2004 | US6673554 Protein localization assays for toxicity and antidotes thereto |
| 01/06/2004 | US6673379 Use of non-alkalized cocoa solids in a drink |
| 01/06/2004 | US6673375 Mostly comprising sodium metasilicate (pentahydrate) and shows nonspecific immunostimulating activity in plants and animals |
| 01/06/2004 | US6673351 Immunotherapeutic agent comprising purified protein extract derived from killed cells of amastigotes and leishmania |
| 01/06/2004 | US6673336 Comprising an inorganic pigment and an active substance based on organic compounds being covalently bound through a group 3b,4a,4b,5b,6b spacer group to the inorganic pigment; sunscreen agents |
| 01/06/2004 | CA2301990C New substitute dimerized derivatives, process for preparing them, and pharmaceutical compounds containing them |
| 01/02/2004 | EP1375645A1 Yeast cells as dietary supplements for enhancing the immune system |
| 01/02/2004 | EP1375641A1 Feed additives for chickens |
| 01/02/2004 | EP1375518A1 Anti-osteopontin antibody and use thereof |
| 01/02/2004 | EP1375513A1 Immunopotentiators |
| 01/02/2004 | EP1375511A2 Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
| 01/02/2004 | EP1374902A1 Remedies for inflammatory bowel diseases |
| 01/02/2004 | EP1374901A1 Graft rejection suppressors |
| 01/02/2004 | EP1373543A2 Method for producing pectin hydrolysis products |
| 01/02/2004 | EP1373517A2 Human kinases |
| 01/02/2004 | EP1373510A2 Mutant allergens |
| 01/02/2004 | EP1373489A2 Human dual specificity protein phosphatase 7-like protein |
| 01/02/2004 | EP1373485A2 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby |
| 01/02/2004 | EP1373475A2 Immunotherapy based on dendritic cells |
| 01/02/2004 | EP1373322A1 Novel compound for treatment of allergy and asthma |
| 01/02/2004 | EP1373319A2 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders |
| 01/02/2004 | EP1373318A2 Neutralizing human monoclonal antibodies against hiv-1, their production and uses |
| 01/02/2004 | EP1373317A2 Nuclear hormone receptor ligand binding domains |
| 01/02/2004 | EP1373316A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373315A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373313A2 Proteins and nucleic acids encoding same |
| 01/02/2004 | EP1373275A2 Highly purified and crystalline form of harringtonine |
| 01/02/2004 | EP1373271A1 Indole derivatives having an inhibitory effect on protein kinases |
| 01/02/2004 | EP1373269A1 Jun kinase inhibitors |
| 01/02/2004 | EP1373263A1 Heterocyclic compounds for aging-related and diabetic vascular complications |
| 01/02/2004 | EP1373261A2 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors |
| 01/02/2004 | EP1373258A1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 01/02/2004 | EP1373257A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/02/2004 | EP1373256A1 Ccr5 antagonists useful for treating aids |
| 01/02/2004 | EP1373251A2 Non-imidazole compounds as histamine h3 antagonists |
| 01/02/2004 | EP1373249A1 Imidazolidine derivatives, their preparation, and their use as antinflamatory agent |
| 01/02/2004 | EP1373242A1 Dimeric isoflavones |